Literature DB >> 21263997

The principles and practice of anticoagulant therapy.

C J Carter.   

Abstract

The author describes the clinical rationale and pharmacology of current anticoagulant therapy. He goes on to discuss the intensity of therapy by means of oral anticoagulants, the means of monitoring this therapy, and the standardization of monitoring procedures. He also describes the indications for and best means of administering and monitoring heparin therapy, together with the major clinical indications for both heparin and oral anticoagulant therapy.

Entities:  

Year:  1987        PMID: 21263997      PMCID: PMC2218685     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  15 in total

1.  Management of heparin therapy: Controlled prospective trial.

Authors:  E W Salzman; D Deykin; R M Shapiro; R Rosenberg
Journal:  N Engl J Med       Date:  1975-05-15       Impact factor: 91.245

2.  Hemorrhagic complications of anticoagulant therapy.

Authors:  M N Levine; J Hirsh
Journal:  Semin Thromb Hemost       Date:  1986-01       Impact factor: 4.180

3.  Thromboplastin and oral anticoagulant control.

Authors:  S M Lewis
Journal:  Br J Haematol       Date:  1987-05       Impact factor: 6.998

4.  Intensity of oral anticoagulation in patients monitored with various thromboplastins.

Authors: 
Journal:  N Engl J Med       Date:  1983-05-19       Impact factor: 91.245

5.  Heparin kinetics in venous thrombosis and pulmonary embolism.

Authors:  J Hirsh; W G van Aken; A S Gallus; C T Dollery; J F Cade; W L Yung
Journal:  Circulation       Date:  1976-04       Impact factor: 29.690

6.  A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery.

Authors:  A G Turpie; M N Levine; J Hirsh; C J Carter; R M Jay; P J Powers; M Andrew; R D Hull; M Gent
Journal:  N Engl J Med       Date:  1986-10-09       Impact factor: 91.245

7.  Randomized prospective trial of continuous vs intermittent heparin therapy.

Authors:  R L Glazier; E B Crowell
Journal:  JAMA       Date:  1976-09-20       Impact factor: 56.272

8.  Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

Authors:  R Hull; J Hirsh; R Jay; C Carter; C England; M Gent; A G Turpie; D McLoughlin; P Dodd; M Thomas; G Raskob; P Ockelford
Journal:  N Engl J Med       Date:  1982-12-30       Impact factor: 91.245

9.  Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism.

Authors:  A Gallus; J Jackaman; J Tillett; W Mills; A Wycherley
Journal:  Lancet       Date:  1986-12-06       Impact factor: 79.321

10.  Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke.

Authors:  A G Turpie; M N Levine; J Hirsh; C J Carter; R M Jay; P J Powers; M Andrew; H N Magnani; R D Hull; M Gent
Journal:  Lancet       Date:  1987-03-07       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.